問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Ophthalmology

更新時間:2024-05-13

何子昌HO, TZYY-CHANG
  • Principal Investigator
  • Clinical Trial Experience (year)
  • hotchang@ntu.edu.tw

篩選

List

3Cases

2018-11-01 - 2023-12-31

Phase III

Completed
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients With Diabetic Macular Edema (RHINE)
  • Condition/Disease

    Diabetic Macular Edema

  • Test Drug

    FARICIMAB (RO6867461)

Participate Sites
3Sites

Terminated3Sites

2024-01-31 - 2027-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2023-04-22 - 2026-10-30

Phase III

Active
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
  • Condition/Disease

    Geographic Atrophy

  • Test Drug

    錠劑

Participate Sites
4Sites

Recruiting4Sites